QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.066712v1 310/3/973    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Papp, L. Articles by Sperlágh, B. Search for Related Content PubMed PubMed Citation Articles by Papp, L. Articles by Sperlágh, B.

NEUROPHARMACOLOGY

P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices

Laboratories of Molecular of Pharmacology (L.P., T.B., B.S.) and Molecular Biology and Genetics (F.E., G.S.) and Department of Pharmacology (E.S.V.), Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary

This study was designed to test the hypothesis of whether activation of presynaptic P2X receptor-gated ion channels elicits noradrenaline release from central catecholaminergic terminals. ATP, ,-methylene-adenosine 5'-triphosphate (,-methyleneATP), and ADP elicited concentration-dependent [³H]noradrenaline outflow from superfused rat hippocampal slices with the following rank order of agonist potency: ,-methyleneATP > ATP > ADP. Among P2 receptor antagonists, pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (30 µM), 4,4',4'',4'''-[carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino))]tetrakis-1,3-benzenedisulfonic acid (100 nM), and 8,8'-[carbonybis(imino-3,1-phenylenecarbonylimino)]bis1,3,5-naphthalenetrisulphonic acid (10 µM) significantly inhibited the outflow of [³H]noradrenaline, evoked by ATP, whereas Brilliant Blue G (100 nM), 2'-deoxy-N⁶-methyladenosine 3',5'-bisphosphate tetraammonium (10 µM), the A₁ receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (250 nM), and the A_2A receptor antagonist 3,7-dimethyl-1-propargylxanthine (250 nM) were ineffective. Pretreatment with the G_i protein inhibitor pertussis toxin (2.5 µg/ml) did not change the effect of ATP on [³H]noradrenaline outflow. In contrast, a decrease in extracellular pH from 7.4 to 6.6 significantly attenuated the response by ATP. When extracellular Na⁺ was replaced by choline chloride and in the presence of the noradrenaline uptake inhibitor desipramine (10 µM), the ATP-evoked [³H]noradrenaline outflow was almost completely abolished, indicating that its underlying mechanism is the sodium-dependent reversal of the noradrenaline transporter. Reverse transcription-polymerase chain reaction analysis revealed that mRNA encoding P2X₁, P2X₂, P2X₃, P2X₄, P2X₆, P2X₇, and P2Y₁ receptor subunits were expressed in the brainstem containing catecholaminergic nuclei projecting to the hippocampus, whereas mRNA encoding P2X₅, P2Y₂, P2Y₄, and P2Y₆ receptors were absent. Taken together, these results indicate that noradrenergic terminals of the rat hippocampus are equipped with presynaptic facilitatory P2X receptors, displaying a pharmacological profile similar to homomeric P2X₁ and P2X₃ receptors.

Address correspondence to: Beáta Sperlágh, Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, POB 67 Hungary. E-mail: sperlagh{at}koki.hu

This article has been cited by other articles:

				G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF]

				H. A. Kluess, J. B. Buckwalter, J. J. Hamann, D. S. DeLorey, and P. S. Clifford Frequency and pattern dependence of adrenergic and purinergic vasoconstriction in rat skeletal muscle arteries Exp Physiol, November 1, 2006; 91(6): 1051 - 1058. [Abstract] [Full Text] [PDF]